CU-CPT4a

CU-CPT4a is a drug which acts as a selective antagonist of Toll-like receptor 3 (TLR3), with an IC50 of 3.44 μM. It is used for research into the function of TRL3 and its role in inflammation, autoimmune disorders and cancer.
Wikipedia contributors, "CU-CPT4a", Wikipedia, revision 1370550533, retrieved 20 November 2026, source, CC BY-SA 4.0.